Navigation Links
Fougera First-to-Market With Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution)
Date:5/6/2008

MELVILLE, N.Y., May 6 /PRNewswire/ -- Today, Fougera, a division of Nycomed US Inc., announced it has received FDA approval to bring to market the first generic Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution). The generic formulation compares to Dovonex(R) by Warner-Chilcott.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080506/NYTU034 )

Fougera's Calcipotriene Topical Solution is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp (see product package insert for full prescribing information). It is available in a 60 mL bottle (NDC # 0168-0400-60).

"Fougera has received more FDA approvals for topical products during the past seven years than any other generic company. Today's announcement that we are first-to-market with Calcipotriene Topical Solution is another example of our ongoing commitment to provide safe, effective and affordable options to health care providers and their patients," stated David Klaum, Senior Vice President, Commercial Business Operations.

Founded in 1849, Fougera is the largest of the three Nycomed US Inc. divisions and is the leading manufacturer and distributor of a wide range of topical steroids, antibiotics and antifungal products. For more information on Fougera's complete line of products, please call Fougera Customer Service at (800) 645-9833 or visit the company online at http://www.fougera.com.

About Nycomed US

Nycomed US, Inc. (formerly ALTANA Inc) is a subsidiary of Nycomed, and also operates two additional divisions in the US focused on specialty pharmaceuticals in dermatology. The PharmaDerm(R) division of Nycomed is dedicated to bringing innovative products to the dermatologists so they can best care for their patients. Nycomed US, Inc. and its PharmaDerm Division recently announced the acquisition of Bradley Pharmaceuticals, a global specialty company with 3 divisions-Doak Dermatologics, Kenwood Therapeutics, and A. Aarons. The Bradley product line will be combined with the current offerings of PharmaDerm, enabling the Company to offer more therapeutic choices and enhanced customer service. Combined with Nycomed's Fougera Division, Nycomed becomes a leader in the dermatology market. Nycomed US also markets and sells Savage Laboratories products, which focus on emergency care.


'/>"/>
SOURCE Fougera
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
2. Topical Cream Treats Precancerous Lesions of Vulva
3. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
4. International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as its First and Only Official Joint and Muscle Topical Cream
5. Summit VetPharm Introduces New Feline Topicals Vectra(TM) for Cats & Kittens and Vectra(TM) for Cats
6. Topical treatment for age spots, from Harvard Womens Health Watch
7. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
8. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
9. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
10. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
11. UHW Outlines Solutions to Californias Health Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... January 15, 2017 , ... Going above and beyond ... strives to better communities around the world by offering the Gensuite team and ... opportunity for team members to become involved in a cause that is bigger ...
(Date:1/15/2017)... Rosa, CA (PRWEB) , ... January 15, 2017 ... ... nominate their choice of best physicians in eight Bay Area counties for 2017. ... by the healthcare research company managing the award process. Results were announced the ...
(Date:1/14/2017)... Minneapolis, MN (PRWEB) , ... January 14, 2017 ... ... to present the distinctions among their expanding line of activated charcoal products. With ... emphasizes the importance of categorizing their products according to how they cater to ...
(Date:1/13/2017)... ... 2017 , ... People with type 2 diabetes know to ... as checking the nutrition label on foods for grams of sugar. But carbohydrates ... proteins can influence — either positively or negatively — insulin secretion and glucose ...
(Date:1/13/2017)... ... January 13, 2017 , ... With the increasing public ... of providing additional organic alternatives for customers who have grown more conscious about ... line of all-natural activated charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... SAN FRANCISCO, Calif. , Jan. 16, 2017 /PRNewswire/ ... that on January 3, 2017 and January 16, 2017 ... the grant of inducement stock options to purchase an ... new employees. These awards were granted pursuant to the ... inducement material to the new employees entering into employment ...
(Date:1/16/2017)... Colo. , Jan. 16, 2017 CBDRx, ... donate large amounts of phyto-nutrient rich hemp extract to ... the donation of their proprietary hemp extract to Veteran,s ... CBDRx the best hemp company in the world and ... best, most nutritious, full spectrum phyto-nutrient rich hemp extract ...
(Date:1/15/2017)... -- Le conseil d,administration de SurgaColl Technologies Ltd., ... la régénération de tissus humains, annonce la nomination de ... effet immédiat. ... Bill est un dirigeant expérimenté à l,international dans l,industrie ... générale et de direction au sein de sociétés internationales spécialisées ...
Breaking Medicine Technology: